Shineco, Inc. (SISI)
USD 0.86
(-5.18%)
USD 0.86
(-5.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 29.29 Million USD | 84.54% |
| 2023 | 15.87 Million USD | 1182.49% |
| 2022 | 1.23 Million USD | 109.8% |
| 2021 | -12.62 Million USD | 57.27% |
| 2020 | -29.53 Million USD | 10.27% |
| 2019 | -32.92 Million USD | -12.85% |
| 2018 | -29.17 Million USD | -42.36% |
| 2017 | -20.49 Million USD | -6.37% |
| 2016 | -19.26 Million USD | -621.18% |
| 2015 | -2.67 Million USD | -538.02% |
| 2014 | -418.65 Thousand USD | -120.54% |
| 2013 | 2.03 Million USD | 0.0% |
| 2006 | 249.73 Thousand USD | 0.0% |
| 2005 | 249.73 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 29.29 Million USD | -0.81% |
| 2024 Q3 | 29.52 Million USD | -1.56% |
| 2024 Q2 | 29.99 Million USD | 3.87% |
| 2024 Q1 | 28.87 Million USD | 81.94% |
| 2023 Q2 | -923.52 Thousand USD | 89.13% |
| 2023 Q4 | 15.87 Million USD | 799.72% |
| 2023 Q3 | 1.76 Million USD | 291.02% |
| 2023 FY | 15.87 Million USD | 1182.49% |
| 2023 Q1 | -8.49 Million USD | -163.03% |
| 2022 Q3 | 986.8 Thousand USD | -7.8% |
| 2022 Q1 | 1.01 Million USD | 108.06% |
| 2022 FY | 1.23 Million USD | 109.8% |
| 2022 Q2 | 1.07 Million USD | 5.2% |
| 2022 Q4 | 13.47 Million USD | 1265.92% |
| 2021 Q2 | -21.97 Million USD | -8.87% |
| 2021 Q3 | -23.47 Million USD | -6.8% |
| 2021 FY | -12.62 Million USD | 57.27% |
| 2021 Q4 | -12.62 Million USD | 46.22% |
| 2021 Q1 | -20.18 Million USD | 31.66% |
| 2020 FY | -29.53 Million USD | 10.27% |
| 2020 Q3 | -37.94 Million USD | 5.03% |
| 2020 Q4 | -29.53 Million USD | 22.15% |
| 2020 Q1 | -34.86 Million USD | -5.92% |
| 2020 Q2 | -39.95 Million USD | -14.57% |
| 2019 Q1 | -28.99 Million USD | 0.59% |
| 2019 Q2 | -33.51 Million USD | -15.58% |
| 2019 Q3 | -31.55 Million USD | 5.85% |
| 2019 Q4 | -32.92 Million USD | -4.33% |
| 2019 FY | -32.92 Million USD | -12.85% |
| 2018 Q2 | -28.14 Million USD | -10.49% |
| 2018 Q3 | -25.95 Million USD | 7.8% |
| 2018 Q4 | -29.17 Million USD | -12.41% |
| 2018 FY | -29.17 Million USD | -42.36% |
| 2018 Q1 | -25.47 Million USD | -24.32% |
| 2017 FY | -20.49 Million USD | -6.37% |
| 2017 Q4 | -20.49 Million USD | 1.28% |
| 2017 Q3 | -20.75 Million USD | 0.41% |
| 2017 Q2 | -20.84 Million USD | 19.65% |
| 2017 Q1 | -25.93 Million USD | -34.66% |
| 2016 Q4 | -19.26 Million USD | -24.86% |
| 2016 Q3 | -15.42 Million USD | -28.46% |
| 2016 Q2 | -12.01 Million USD | -41.16% |
| 2016 Q1 | -8.5 Million USD | -218.54% |
| 2016 FY | -19.26 Million USD | -621.18% |
| 2015 Q2 | -5.28 Million USD | -271.11% |
| 2015 Q4 | -2.67 Million USD | 27.59% |
| 2015 Q3 | -3.68 Million USD | 30.23% |
| 2015 Q1 | 3.08 Million USD | 838.04% |
| 2015 FY | -2.67 Million USD | -538.02% |
| 2014 Q3 | 2.77 Million USD | 0.0% |
| 2014 Q1 | 1.96 Million USD | -18.59% |
| 2014 FY | -418.65 Thousand USD | -120.54% |
| 2014 Q4 | -418.65 Thousand USD | -115.1% |
| 2013 FY | 2.03 Million USD | 0.0% |
| 2013 Q4 | 2.41 Million USD | 0.0% |
| 2007 Q2 | 772.58 Thousand USD | 209.36% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q1 | 249.73 Thousand USD | 0.0% |
| 2006 FY | 249.73 Thousand USD | 0.0% |
| 2006 Q3 | 576.1 Thousand USD | 0.0% |
| 2006 Q1 | -101.16 Thousand USD | 0.0% |
| 2005 FY | 249.73 Thousand USD | 0.0% |
| 2005 Q3 | -59.03 Thousand USD | -123.64% |
| 2005 Q2 | 249.73 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | -1490.374% |
| Alpha Teknova, Inc. | 1.97 Million USD | -1383.805% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 68.909% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 60.92% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 93.272% |
| Cosmos Health Inc. | 8.59 Million USD | -240.951% |
| Journey Medical Corporation | -9.7 Million USD | 401.682% |
| Embecta Corp. | 1.31 Billion USD | 97.768% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 93.614% |
| Dynavax Technologies Corporation | 106.63 Million USD | 72.532% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 122.388% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 93.232% |
| PainReform Ltd. | -7.95 Million USD | 468.431% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 287.342% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 287.342% |
| SCYNEXIS, Inc. | -19.35 Million USD | 251.371% |
| Safety Shot Inc | -2.28 Million USD | 1382.202% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 410.617% |
| Procaps Group, S.A. | 242.93 Million USD | 87.943% |
| Theratechnologies Inc. | 24.87 Million USD | -17.769% |
| Harrow Health, Inc. | 116.41 Million USD | 74.84% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 1262.314% |
| Biofrontera Inc. | 4.05 Million USD | -622.148% |
| DURECT Corporation | -7.65 Million USD | 482.68% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 187.363% |
| Cronos Group Inc. | -663.32 Million USD | 104.416% |
| OptiNose, Inc. | 58.06 Million USD | 49.556% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 95.301% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 301.004% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 664.792% |
| Organogenesis Holdings Inc. | 15.01 Million USD | -95.1% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 560.565% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -27310.236% |
| Radius Health, Inc. | 359.28 Million USD | 91.848% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -14752.417% |
| ProPhase Labs, Inc. | 19.23 Million USD | -52.308% |
| Phibro Animal Health Corporation | 454.84 Million USD | 93.56% |
| Procaps Group S.A. | 242.93 Million USD | 87.943% |
| Alvotech | 1.06 Billion USD | 97.248% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -696.365% |
| Viatris Inc. | 17.13 Billion USD | 99.829% |
| Rockwell Medical, Inc. | 4.45 Million USD | -557.323% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 700.58% |
| SIGA Technologies, Inc. | -148.68 Million USD | 119.7% |
| Tilray Brands, Inc. | 158.97 Million USD | 81.576% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 75.971% |
| PetIQ, Inc. | 351.93 Million USD | 91.677% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 1109.513% |
| Incannex Healthcare Limited | -5.48 Million USD | 634.007% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 83.48% |
| Alimera Sciences, Inc. | 55.3 Million USD | 47.042% |
| Silver Spike Investment Corp. | -32.61 Million USD | 189.816% |
| Assertio Holdings, Inc. | -32.52 Million USD | 190.044% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 2067.48% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 678.816% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 708.44% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 456.613% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -594.577% |
| Hempacco Co., Inc. | 13.61 Million USD | -115.138% |
| Talphera, Inc. | -5.72 Million USD | 611.979% |
| Alvotech | 1.06 Billion USD | 97.248% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | -309.941% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 130.287% |
| Currenc Group, Inc. | -16.57 Million USD | 276.734% |
| Kamada Ltd. | -46.43 Million USD | 163.083% |
| Indivior PLC | -33.95 Million USD | 186.27% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -11140.686% |
| Flora Growth Corp. | -713 Thousand USD | 4208.037% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 456.613% |
| Evolus, Inc. | 63.7 Million USD | 54.024% |
| HUTCHMED (China) Limited | -197.45 Million USD | 114.834% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 93.887% |
| Akanda Corp. | 3.9 Million USD | -650.088% |